Status:
COMPLETED
A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache
Lead Sponsor:
Kern Medical Center
Conditions:
Migraine Headache
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a small study. Using a nebulizer to administer the drug would improve the feasibility of using the treatment. ...
Eligibility Criteria
Inclusion
- Meets IHS criteria for migraine
Exclusion
- Pregnant
- Breast feeding
- Allergic to Lidocaine
- Worst or first Headache
- Abnormal neurological exam
- Substance abuse within 6 months
- Cardiac, liver or pulmonary disease
- Participation n another study within 30 days
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00287781
Start Date
January 1 2002
End Date
April 1 2006
Last Update
January 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kern Medical Center
Bakersfield, California, United States, 93305